-
2024-515010-40-00
5
2022-03-28
Hemoptysis, whatever the cause, with the exception of cystic fibrosis
-
2024-518053-42-00
6
2022-02-09
lumbosacral radiculalgia
-
2024-513023-17-00
5
2022-01-12
Treatment of acute graft-versus host disease (aGvHD) to the gastrointe
-
2022-500752-39-00
5
2021-11-25
Prevention of Respiratory syncytial virus (RSV) infection in infants a
-
2024-512227-36-00
9
2021-07-28
Advanced solid tumors
-
2023-505203-23-01
5
2021-07-26
Severe asthma with an eosinophilic phenotype
-
2024-513672-17-00
4
2021-06-14
Inoperable Chronic thromboembolic pulmonary hyperTension
-
2022-501252-28-00
4
2021-04-15
Non Small Cell Lung cancer
-
2023-505273-33-00
5
2021-02-15
"Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial
(NTM
-
2024-512456-38-00
4
2021-02-04
locally advanced squamous cell carcinoma
-
2023-505894-33-00
4
2020-11-25
Lung Cancer, Non-Small Cell
-
2023-505035-12-00
5
2020-06-12
RET fusion−positive, metastatic Non-Small Cell Lung Cancer
-
2024-511427-34-00
5
2020-02-20
idiopathic pulmonary fibrosis
-
2022-501439-18-00
5
2019-06-26
NSCLC with squamous or nonsquamous histology
-
2023-508449-41-00
5
2019-06-26
Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
-
2023-509774-40-00
5
2019-06-25
Stage IV lung cancer condition
-
2023-503673-38-00
5
2019-05-24
Adults at high risk of cardiovascular events without prior MI or strok
-
2022-500395-57-00
5
2019-03-04
Resectable high-risk Locally Advanced Cutaneous Squamous Cell Carcinom
-
2023-510426-33-00
5
2018-09-27
Moderately to Severely Active Crohn's Disease
-
2024-515356-21-00
5
2018-04-17
Adult subject (18 years of age older) with low or intermediate-1 IPSS
-
2023-508757-75-00
5
2017-09-18
Stage IV Non-Small Cell Lung Cancer (NSCLC)
-
2023-509769-18-00
5
2017-03-15
Hereditary severe von Willebrand Disease in children
-
2023-504034-22-00
5
2014-12-18
Chronic Lymphocytic Leukemia (CLL)
-
2022-502822-41-00
9
Relapsed/Refractory Diffuse Large B Cell Lymphoma